Institutional investors purchased a net $959.1 thousand shares of OHRP during the quarter ended December 2014, and now own 34.48% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BROADFIN CAPITAL LLC Bought 1.8 Million shares of OHR Pharmaceutical Inc